Skip to main content

How DEA Compliance is Adapting to the Pandemic!

The DEA’s oversight on prescription drug practices continues to be the same during the ongoing pandemic. However, there has been some easing with special guidance in specific areas of concern.

The U.S. Drug Enforcement Administration (DEA) continues to enforce its laws and regulations for prescribing, handling and dispensing controlled substance medications even in the face of the unprecedented COVID-19 pandemic. DEA compliance is expected to be a top priority for doctors, hospitals, pharmacies and other providers just like in 2019 and earlier. However, the agency has proactively assessed some of the specific areas of concern thrown up by the enormous healthcare challenges of the ongoing public health crisis and issued guidance and advise accordingly. 

Dispensing Across State Lines – The DEA has temporarily eased practitioner registration with the agency when practicing in additional states. Given that many states have granted reciprocity to neighboring states and their practitioners to practice across state lines, the DEA is also making the exception of allowing registered health care providers to dispense prescription medications across state lines even if they are registered only in a single state. In normal circumstances, practitioners are required to register in each state where they dispense controlled substances. However, the providers should still be licensed to practice in each state and must comply with the laws of both states.

5% Distribution Rule – Registered health care providers are temporarily allowed to distribute more than 5% of their total dosage units to other registered providers as long as they continue to abide by all security, recordkeeping and other applicable DEA regulations.

Early Refills – The DEA is also permitting the diktat of some states allowing pharmacies to dispense early refills of controlled substances due to the COVID-19 emergency. However, the prohibitions against refills of Schedule II controlled substances continue to apply.

Telemedicine – In view of the new challenges, the DEA further permits authorized practitioners to prescribe schedule II-V controlled substances via tele-consultation evenwithout a prior in-person medical examination. However, the practitioner is required to ensure that:


  • He/she issues the prescription for a legitimate medical purpose within the usual course of professional practice.
  • The virtual consultation is conducted via ‘an audio-visual, real-time, two-way interactive communication system’.
  • The controlled substance is issued in full compliance with all other pertinent state and federal laws.

Moreover, the providers are permitted to prescribe scheduled drugs via telemedicine to patients in states in which they are not DEA-registered.

Oral prescriptions – While emergency oral prescriptions for Schedule II controlled substances have to be mandatorily followed up with a paper copy within 7 days to the pharmacy, practitioners are now allowed a 15 day window for the same. Furthermore, the practitioners are also permitted to send the follow-up prescription as a facsimile, photograph or scan to the pharmacy in place of the paper prescription. However, it should have the statement, ‘Authorization for Emergency Dispensing’ while the original paper prescription should be maintained in the patient file.

Apart from this, all other regulations regarding DEA forms for controlled substances, inventory management, record-keeping, storage, disposal, diversion prevention, etc. continue to apply as earlier.

Comments

Popular posts from this blog

Compliance Provisions for Hiring People with Access to Controlled Substances

It is not just the DEA registrant who is subject to strict regulations. The provisions also extend to staff members who will have access to the controlled substances. Those convicted for felony are barred forever. Everyone is well aware that the manufacture, distribution, administering and dispensing of controlled substances is subject to a bevy of federal, state and local regulations. The DEA controlled substance regulations itself are very exacting and the federal agency keeps strict tabs on all those entities who deal with such substances. The rules encompass even the hiring of staff who will administer, dispense or otherwise come in contact with the controlled substances. Indeed, healthcare providers and other entities are bound to carefully screen new employees and other staff members. However, they also have to run a criminal background check for those positions that will have access to controlled substances. Along with this, they should review the OIG (Office of the Inspector G...

Beware of Scammers Posing as DEA Agents

Scammers are impersonating DEA employees to defraud and extort DEA license holders through fake narratives of abusing controlled substances. People should be on their guard as the tactics are convincing. The Drug Enforcement Administration (DEA) maintains constant oversight over the supply and usage of scheduled drugs in the country. They enforce the DEA controlled substance regulations while keeping track of registered healthcare practitioners and pharmacists who prescribe, administer and dispense these drugs. Unscrupulous scamsters are using these regulations in innovative ways to swindle unsuspecting physicians and other DEA registrants. The scams have been taking place on and off since years and follow a similar format to a large extent. The fraudster usually calls the victim impersonating as a DEA agent. They may provide the name of a well-known DEA agent or use fake names and badge numbers. They may even quote the target’s Social Security Number or state license number while sta...

Changes Regarding DEA Application Regulations

Those applying for DEA registration and existing registrants have to keep abreast of the changes in the regulations to ensure that they do not run afoul even unintentionally on any occasion. The U.S. law clearly mandates that every physician, nurse, veterinarian or pharmacist that prescribes, administers or dispenses controlled substances should have a controlled substance license registration issued by the federal Drug Enforcement Administration (DEA). Any person can apply for the DEA license using the DEA Form 224. Manufacturers, distributors, researchers, importers and exporters should use DEA Form 225. Complete instructions accompany the forms. These forms are available on the DEA website and could also be obtained by contacting the DEA field office or headquarters. However, since May last year, the DEA regulations have been amended to require all applications for both DEA new registration and renewal to be submitted online only. Indeed, from 11th May, 2022, the DEA has stopped ac...